Although rates of SH in children and adolescents have decreased significantly in the past two decades, due to improvements in insulin administration and monitoring technologies (e.g., continuous subcutaneous insulin infusion and continuous glucose monitoring) [5–7], a recent systematic review still reported an incidence of 1.21–30 events per 100 person-years in young people with type 1 diabetes [8]. Here, INS is linked to type 1 diabetes mellitus.